Form 4 for BSX Boston Scientific
Accepted 2026-08-03 16:29:42 ET · period of report 2026-07-31 · accession 0001225208-26-006881 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-08-03 16:29 | 2026-07-31 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | I - Discretionary | $46.73 | +64.2K | 64.2K | New | +$3.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-31 | I | A | 64,198 | $46.73 | 64,198 | I By 401(k) | — | — | (F1) Acquistion made pursuant to an election by the reporting person to rebalance their holdings under the Company's 401(k) Retirement Savings Plan, which resulted in a discretionary transaction in shares of the Company's common stock. (F2) Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan. |